A retrospective analysis of 4000 patients with obstructive sleep apnea in Okinawa, Japan

Sleep and Biological Rhythms

Volumn 7, Issue 2, 2009, Pages 103-112

  Nakamura, Hiroshi ^a   Kanemura, Takashi ^a   Takara, Chikashi ^a   Tsukayama, Akira ^a   Tohyama, Kazuyo ^a   Matsumoto, Tsuyoshi ^a   Iseki, Kunitoshi ^b  

^a Sleep Respiratory Center   (Japan)

^b UNIVERSITY OF THE RYUKYUS   (Japan)

Author keywords

Body weight; Causeof death; Continuous positive airway pressure; Mortality; Obstructive sleep apnea (OSA); Pulmonary impairment

Indexed keywords

ADULT; AGE; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; JAPAN; LUNG DISEASE; LUNG FUNCTION; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBESITY; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; REGISTER; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEX DIFFERENCE; SLEEP APNEA SYNDROME; SURVIVAL RATE; TREATMENT RESPONSE; AGE DISTRIBUTION; AGED; APNEA HYPOPNEA INDEX; CONTROLLED STUDY; DISEASE REGISTRY; HIGH RISK POPULATION; MORTALITY RISK; RISK REDUCTION; SLEEP DISORDERED BREATHING;

EID: 66549102414     PISSN: 14469235     EISSN: 14798425     Source Type: Journal    
DOI: 10.1111/j.1479-8425.2009.00395.x     Document Type: Article

References (36)

1. Young T, Palta M, Dempsey J et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl. J. Med. 1993; 328: 1230-35.
2. Peker Y, Hedner J, Norum J et al. Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: A 7-year follow-up. Am. J. Respir. Crit. Care Med. 2002; 166: 159-65.
3. Marin JM, Carrizo SJ, Vicente E et al. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: An observational study. Lancet 2005; 365: 1046-53.
4. National Task Force on the Prevention and Treatment of Obesity. Overweight, obesity, and health risk. Arch. Intern. Med. 2000; 160: 898-904.
5. National Institutes of Health. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults: The Evidence Report. Obes. Res. 1998; 6 (Suppl. 2): 51S-209S.
6. Curtis JP, Selter JG, Wang Y et al. The obesity paradox: Body mass index and outcomes in patients with heart failure. Arch. Intern. Med. 2005; 10: 55-61.
7. Escalante A, Haas RW, del Rincon I. Paradoxical effect of body mass index on survival in rheumatoid arthritis. Arch. Intern. Med. 2005; 165: 1624-9.
8. Kalantar-Zadeh K, Abbott KC, Salahudeen AK et al. Survival advantage of obesity in dialysis patients. Am. J. Clin. Nutr. 2005; 81: 543-54.
9. Sullivan CE, Issa FG, Berthon-Jones M et al. Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares. Lancet 1981; 1: 862-5.
10. He J, Kryger MH, Zorick FJ et al. Mortality and apnea index in obstructive sleep apnea. Experience in 385 male patients. Chest 1988; 94: 9-14.
11. Doherty LS, Kiely JL, Swan V et al. Long-term effects of nasal continuous positive airway pressure therapy on cardiovascular outcomes in sleep apnea syndrome. Chest 2005; 127: 2076-84.
12. Campos-Rodriguez F, Pena-Grinan N, Reyes-Nunez N et al. Mortality in obstructive sleep apnea-hypopnea patients treated with positive airway pressure. Chest 2005; 128: 624-33.
13. Chaouat A, Weizenblum E, Krieger J et al. Prognostic value of lung function and pulmonary heamodynamics in OSA patients treated with CPAP. Eur. Respir. J. 1999; 13: 1091-6.
14. Wilson DO, Rogers RM, Wright EC et al. Body weight in chronic obstructive pulmonary disease. The National Institutes of Health Intermittent Positive-Pressure Breathing Trial. Am. Rev. Respir. Dis. 1989; 139: 1435-8.
15. Chailleux E, Laaban JP, Veale D. Prognostic value of nutritional depletion in patients with COPD treated by long-term oxygen therapy: data from the ANTADIR observatory. Chest 2003; 123: 1460-6.
16. Tojo N, Suga H, Kambe M. [Lung function testing - the official guidelines of the Japanese Respiratory Society.] Rinsho Byori 2005; 53: 77-81. (Review in Japanese.)
17. American Academy of Sleep Medicine. Sleep-related breathing disorders in adults: The Report of an American Academy of Sleep Medicine Task Force. Sleep 1999; 22(5): 667-89.
18. Japan Society for the Study of Obesity. Examination Committee of Criteria for "Obesity Disease" in Japan: New criteria for "obesity disease" in Japan. Circ. J. 2002; 66: 987-92.
19. World Health Organization (WHO). Obesity: Preventing and Managing the Global Epidemic. Report of a WHO Consultation on Obesity; 3-5 June 1997, Geneva, Switzerland. WHO: Geneva, 1997.
20. Ministry of Health and Welfare Health Insurance Bureau Medical Economics Division, eds. Notification of all social insurance medical fees. Igaku tsuusin-sha, Tokyo, Japan, 1998.
21. Lavie P, Herer P, Peled R et al. Mortality in sleep apnea patients: A multivariate analysis of risk factors. Sleep 1995; 18: 149-57.
22. Veale D, Chailleux E, Hoorelbeke-Ramon A et al. Mortality of sleep apnoea patients treated by nasal continuous positive airway pressure registered in the ANTADIR observatory. Eur. Respir. J. 2000; 15: 326-31.
23. Ministry of Health, Labour and Welfare. 2001 Jinko dotai tokei geppo nenkei (gaisu) no gaikyo (in Japanese). [Cited 19 Nov 2006.] http://www.mhlw.go.jp/toukei/saikin/hw/jinkou/geppo/nengai01/index.html
24. Bradley TD, Logan AG, Kimoff RJ et al. CANPAP Investigators. Continuous positive airway pressure for central sleep apnea and heart failure. N Engl. J. Med. 2005; 353: 2025-33.
25. Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea: A population health perspective. Am. J. Respir. Crit. Care Med. 2002; 165: 1217-39.
26. Lavie P, Lavie L, Herer P. All-cause mortality in males with sleep apnoea syndrome: Declining mortality rates with age. Eur. Respir. J. 2005; 25: 514-20.
27. Marti S, Sampol G, Munoz X et al. Mortality in severe sleep apnoea/ hypopnoea syndrome patients: Impact of treatment. Eur. Respir. J. 2002; 20: 1511-18.
28. Veale D, Chailleux E, Hoorelbeke-Ramon S et al. Mortality of sleep apnoea patients treated by nasal continuous positive airway pressure registered in the ANTADIR observatory. Eur. Respir. J. 2000; 15: 326-31.
29. Chaouat A, Weizenblum E, Krieger J et al. Prognostic value of lung function and pulmonary heamodynamics in OSA patients treated with CPAP. Eur. Respir. J. 1999; 13: 1091-6.
30. Marti S, Munoz X, Rios J et al. Body weight and comorbidity predict mortality in COPD patients treated with oxygen therapy. Eur. Respir. J. 2006; 27: 689-96.
31. Willett WC, Dietz WH, Colditz GA. Guidelines for healthy weight. N. Engl. J. Med. 1999; 341: 427-34.
32. Adams KF, Schatzkin A, Harris TB et al. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71years old. N. Engl. J. Med. 2006; 355: 763-78.
33. Rosenbaum M, Leibel RL, Hirsch J. Obesity. N. Engl. J. Med. 1997; 337: 396-407.
34. Punjabi NM, Shahar E, Redline S et al. Sleep Heart Health Study Investigators. Sleep-disordered breathing, glucose intolerance, and insulin resistance: The Sleep Heart Health Study. Am. J. Epidemiol. 2004; 160: 521-30.
35. McNicholas WT. Compliance with nasal CPAP therapy for obstructive sleep apnoea: How much is enough? Eur. Respir. J. 1997; 10: 969-70.
36. Rauscher H, Formanek D, Popp W et al. Self-reported versus measured compliance with nasal CPAP for obstructive sleep apnea. Chest 1993; 103: 1675-80.